Considering the importance of the FGF19/ELF4/FGFR4 positive feedback circuit in CRC metastasis, we attempted to develop a novel therapeutic strategy to break this loop and achieve satisfactory clinical results. The gene discussed is FGFR4; the disease is colorectal carcinoma.